Expertise in
2
conditions

Amelie Ryckewaert

Rennes, FR 
Expertise in
2
conditions
Rennes, FR 

Overview

Amelie Ryckewaert practices practicing medicine in Rennes, France.

Ms. Ryckewaert is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Nephrocalcinosis, Bartter Syndrome, Hypercalcemia, and Milk-Alkali Syndrome.

She is actively involved in clinical research, co-authoring 20 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Rennes, France
Other Locations
Bordeaux, France
Caen, 14033, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Early Treatment With the Monoclonal C5 Antibody Eculizumab in Pediatric Patients Affected by Shiga-toxin Related Hemolytic and Uremic Syndrome: A Phase III Prospective Randomized Controlled Therapeutic Trial Versus Placebo
Early Treatment With the Monoclonal C5 Antibody Eculizumab in Pediatric Patients Affected by Shiga-toxin Related Hemolytic and Uremic Syndrome: A Phase III Prospective Randomized Controlled Therapeutic Trial Versus Placebo
Enrollment Status: Completed
Publish Date: May 04, 2026
Intervention Type: Drug
Study Phase: Phase 3
Multicentre Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves
Multicentre Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves
Enrollment Status: Unknown
Publish Date: August 23, 2023
View 1 Less Clinical Trial

20 Total Publications

The recurrent p.Glu3Lys variant in EHHADH is responsible for Fanconi syndrome with early liver dysfunction and mitochondrial abnormalities.
The recurrent p.Glu3Lys variant in EHHADH is responsible for Fanconi syndrome with early liver dysfunction and mitochondrial abnormalities.
Journal: Molecular genetics and metabolism reports
Published: January 30, 2025

Frequently Asked Questions about Amelie Ryckewaert

Is Amelie Ryckewaert a top-rated expert for Nephrocalcinosis?

MediFind is an objective health platform that identifies experts based on real-world data. Amelie Ryckewaert is classified as an Advanced expert for Nephrocalcinosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Amelie Ryckewaert participate in research or clinical trials?

Yes. Amelie Ryckewaert has published 20 articles and abstracts on conditions like Nephrocalcinosis. You can view a list of Amelie Ryckewaert's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ryckewaert's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile